Ventyx Biosciences, Inc. (VTYX)

USD 2.3

(-2.95%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019
Revenue - - - - -
Cost of Revenue 941 Thousand 470 Thousand 30 Thousand - -
Gross Profit -941 Thousand -470 Thousand -30 Thousand - -
Operating Expenses 207.99 Million 113.13 Million 67.14 Million 7.05 Million 4.18 Million
Selling, General and Administrative Expenses 32.22 Million 25.39 Million 8.66 Million 684 Thousand 628 Thousand
Research and Development Expenses 175.76 Million 87.73 Million 58.48 Million 6.36 Million 3.55 Million
Other Expenses - 41 Thousand -5.44 Million -1000.00 -1000.00
Cost and Expenses 207.99 Million 113.13 Million 67.14 Million 7.05 Million 4.18 Million
Operating Income -207.99 Million -113.13 Million -67.14 Million -7.05 Million -4.18 Million
Interest Expense - - 99 Thousand 358 Thousand 146 Thousand
Income Tax Expense - -470 Thousand -5.38 Million 358 Thousand 146 Thousand
Earnings before Tax -192.96 Million -108.42 Million -83.74 Million -28.17 Million -4.32 Million
Net Income -192.96 Million -107.95 Million -78.36 Million -28.53 Million -4.47 Million
Earnings Per Share Basic -3.30 -2.06 -1.55 -0.57 -0.09
Earnings Per Share Diluted -3.30 -2.06 -1.55 -0.57 -0.09
Weighted Average Shares Outstanding 58.54 Million 52.47 Million 50.4 Million 50.29 Million 50.29 Million
Weighted Average Shares Outstanding (Diluted) 58.54 Million 52.47 Million 50.4 Million 50.29 Million 50.29 Million
Gross Margin - - - - -
EBIT Margin - - - - -
Profit Margin - - - - -
EBITDA -207.83 Million -107.95 Million -67.11 Million - -1000.00
Earnings Before Tax Margin - - - - -

Income Statement Charts